A Retrospective Study of Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer in Greece (The "RESPONSE" Study).
Phase of Trial: Phase IV
Latest Information Update: 12 Mar 2012
At a glance
- Drugs Fulvestrant (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms RESPONSE
- 12 Mar 2012 Actual end date Sep 2011 added as reported by ClinicalTrials.gov.
- 12 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jul 2011 New trial record